Vanguard Group
THRD

Vanguard Group’s Third Harmonic Bio THRD Stock Holding History

Vanguard Group’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,298,089
Closed -$7.05M – 4426
2025
Q2 		$7.05M Buy
1,298,089
+138,489
+12% +$691K ﹤0.01% 3083
2025
Q1 		$4.02M Buy
1,159,600
+129,613
+13% +$628K ﹤0.01% 3260
2024
Q4 		$10.6M Buy
1,029,987
+138,338
+16% +$1.72M ﹤0.01% 2924
2024
Q3 		$12.1M Buy
891,649
+17,853
+2% +$221K ﹤0.01% 2862
2024
Q2 		$11.4M Buy
873,796
+22,404
+3% +$277K ﹤0.01% 2842
2024
Q1 		$8.04M Buy
851,392
+11,512
+1% +$112K ﹤0.01% 3085
2023
Q4 		$9.21M Buy
839,880
+66,422
+9% +$526K ﹤0.01% 2989
2023
Q3 		$4.94M Buy
773,458
+3,615
+0.5% +$22.1K ﹤0.01% 3253
2023
Q2 		$3.7M Buy
769,843
+21,897
+3% +$104K ﹤0.01% 3441
2023
Q1 		$3.08M Buy
747,946
+51,576
+7% +$219K ﹤0.01% 3516
2022
Q4 		$2.99M Buy
696,370
+596,370
+596% +$9.98M ﹤0.01% 3518
2022
Q3 		$1.9M Buy
+100,000
New +$1.8M ﹤0.01% 3764

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group's THRD Position: Q3 2025 in Review

Vanguard Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 1,298,089 shares — an estimated $7.05M sold.

Vanguard Group first reported a position in THRD in Q3 2022 and held it in 12 quarters. The position peaked at $12.1M in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Vanguard Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Vanguard Group sold 1,298,089 Third Harmonic Bio shares in Q3 2025, an estimated $7.05M.
  • Vanguard Group first reported a position in Third Harmonic Bio in Q3 2022 and held it in 12 quarters.
  • Vanguard Group's Third Harmonic Bio position peaked at $12.1M in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.